Fiocruz

Fundación Oswaldo Cruz una institución al servicio de la vida

Início do conteúdo

Diagnosis of human cell lymphotropic virus HTLV-1/2 infection

Portfolio de Inovação
Diagnosis of human cell lymphotropic virus HTLV-1/2 infection
Baixar em PDF: | Compartilhar:

Problema

There is a lack of methodologies for the universal and differential diagnosis of HTLV-1/2 (human T-cell lymphotropic virus). The high cost of the tests available for the differential diagnosis of HTLV-1/2 infection represents a major challenge in controlling diseases associated with this virus, such as leukemia and neurological problems. It is estimated that there are more than 10 million cases of HTLV in the world.

Solução

The technology consists of a serological immunofluorescence method using flow cytometry for the universal and differential diagnosis of HTLV-1 and HTLV-2 infection. The solution is based on the simultaneous analysis of IgG1 antibody reactivity. The method allows confirmatory diagnosis of the disease in just one step, without the need to collect different types and samples. This methodology can still be used as a more accurate prognosis for the patient. In other words, it is possible to check how the disease progresses in each patient.

Diferencial


apps
Single platform
center_focus_strong
High sensitivity and specificity
face
Easy execution

Estágio de Desenvolvimento


O que buscamos?

Technology licensing agreement

Inventores

Olindo Assis Martins Filho
Andrea Teixeira de Carvalho
Kelly Alves Bicalho Carvalho
Jordana Grazziela Alves Coelho dos Reis
Vanessa Peruhype Magalhães Pascoal

Propriedade Intelectual

Tipo
Patente de Invenção
Descrição
Patent application filed in Brazil

 

 

 

Use your phone camera to scan the QR Code:

 

Campus Fiocruz Maré - Av. Brasil, 4036 - Maré, Rio de Janeiro - RJ

CEP: 21040-361

     
  portfolio@fiocruz.br 
     
  +55 (21) 3282-9080 

 

   
   
   

 

Volver arribaVolver